Target intelligence / Profile preview

Arginine deiminase system (ADS) (ADS)

Target
ADS
Molecular classification
Enzyme, Transporter, Other
01

Overview

The Arginine deiminase system (ADS) is a multi-enzyme metabolic pathway found in various commensal oral bacteria, such as Streptococcus sanguinis and Streptococcus gordonii, that plays a critical role in maintaining pH homeostasis within the dental biofilm (Nascimento et al., 2014). The system consists of three enzymes—arginine deiminase, ornithine carbamoyltransferase, and carbamate kinase—along with an arginine-ornithine antiporter that facilitates the transport of arginine into the cell (Burne & Marquis, 2000). By catabolizing L-arginine into ammonia, carbon dioxide, and ATP, the ADS generates alkali that neutralizes the organic acids produced by cariogenic bacteria like Streptococcus mutans (Liu et al., 2012). This acid neutralization helps prevent the demineralization of tooth enamel and promotes a microbial environment associated with oral health (Jakubovics et al., 2015). Consequently, the ADS is a significant therapeutic target in preventive dentistry, with L-arginine being used as a prebiotic substrate in oral care products to enhance the system's activity (He et al., 2016). Clinical studies have demonstrated that supplementing the oral environment with arginine can shift the biofilm composition toward beneficial species and reduce the incidence of dental caries (Nascimento et al., 2014).

Other names
Arginine deiminase pathwayADI pathwayArc systemArginine-ornithine antiporter system
02

Mechanism of action

Substrate supplementation to enhance bacterial ammonia production, which neutralizes plaque acidity and promotes a healthy microbial shift.

03

Biological functions

Other
04

Disease associations

InfectionOther
05

Safety considerations

Potential for shifting microbial ecologyEfficacy dependence on the presence of ADS-positive bacteria in the host biofilm
06

Interacting drugs

L-arginine

1 more in the full profile.

07

Biomarkers

Arginine deiminase activitySalivary ammonia concentrationBiofilm pHAbundance of ADS-positive streptococci

Beyond the preview

Go deeper on Arginine deiminase system (ADS) (ADS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arginine deiminase system (ADS) (ADS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call